Home / Contributors / Michael E. Thase
Michael E. Thase

Michael E. Thase, MD

Dr. Thase is an expert in assessment and treatment of mood disorders, with particular interest in major depressive disorders, long-term treatment and combination therapy. His current PI work includes a study of cognitive therapy for depression treatment, a multi-site investigation of psychotherapy and medication in addressing major depression, and a placebo-controlled, randomized clinical trial on the use of continuation-phase cognitive therapy and fluoxetine for major depressive disorder. In addition, Dr. Thase is editor-in-chief of Psychopharmacology Bulletin.


Positions

 

Education

 

Relevant Publications

 

Contributed Content